Ozone and Pulsed Electro-Magnetic Field Therapies Improve Endometrial Lining Thickness in Frozen Embryo Transfer Cycles. Three Case Reports
Ozone and Pulsed Electro-Magnetic Field Therapies Improve Endometrial Lining Thickness in Frozen Embryo Transfer Cycles. Three Case Reports
Ozone and Pulsed Electro-Magnetic Field Therapies Improve Endometrial Lining Thickness in Frozen Embryo Transfer Cycles. Three Case Reports
REVIEWED BY:
Aakansha Gupta
15/IBT/001
CONTENTS
• INTRODUCTION
• METHODOLOGY
• CASE STUDIES
• CONCLUSION
• LIMITATIONS
• SUGGESTIONS
INTRODUCTION
• Frozen Embryo Transfer : A frozen embryo transfer
(FET) is a cycle in which the frozen embryos from a
previous fresh IVF or donor egg cycle are thawed and
then transferred back into the woman's uterus.
• The HOCATT infuses CO2 gas into the chamber at 5 L/ PM, which will
then mixes with the steam (H2O) in order to form Carbonic Acid
(H2CO3).
• Carbon far infrared ray (FIR) pads (set at 100%), together with
steam, are used to raise body temperature. It also contains a heart
rate monitor, an oxygen humidifier container for pure oxygen
breathing (at 2.5 L/PM) and a Pulsed Electro-Magnetic Field
(PEMF) stand.
• Each participant would ideally have 2 sessions per week for 3 weeks
(total of 6 sessions). Each session is approximately 30 minutes.
The first session starts with 50% ozone concentration which is then
increased to 60% ozone concentration in the second session, 70%
ozone concentration in the third session, and 80% ozone
concentration in the fourth, fifth and sixth sessions.
Figure 1: HOCATT MACHINE
Source of Image:
https://www.google.com/search?q=HOCATT&source=lnms&tbm=isch&sa=X&ved=0ahUKEwiEsfL9
7qzlAhWIfn0KHYVCCJAQ_AUIEygC&biw=1366&bih=657#imgrc=pqgtraVjyuvljM
PARAMETER CASE I CASE II CASE III
INTRODUCTIO 36 year old with 38year old healthy 37year old healthy
N iatrogenic premature patient with severely patient undergoing
ovarian insufficiency. diminished ovarian FET using her own
FET via donor oocyte. reserve. FET via euploid embryos.
donor oocyte.
MEDICAL Controlled type 1 No significant No significant
HISTORY diabetes, Last menses 3 medical history. medical history. A
years ago, Terminated hysteroscopy with
pregnancy once by dilatation and
dilatation and curretage curretage for
menorrhagia.
MALE Normal Normal Normal
PARTNER
SEMEN
ANALYSIS
EXAMINATION Hysteroscopy: Ovaries Sonography: Small Sonography: Normal
PRE- with normal uterus and ovaries with a normal ovaries & uterus with
TREATMENT 3mm EMT. uterus with 3.5mm EMT of 2-3mm with
EMT. Normal areas of EMT 0mm.
hysteroscopy. Normal hysteroscopy.
TREATMENT Evaluation of response to Exogenous Exogenous
(MOCK exogenous hormones for 4 hormones for 2 hormones for 2
CYCLE) weeks via estradiol 4mg- weeks , lining weeks , lining
8mg, no significant reached 4.5mm reached 4mm
improvement, showed maximum maximum
5mm EST. thickness. thickness.
OST 2 sessions of OST/week for 2 sessions of 2 sessions of
TREATMENT 3 weeks, & oral estradiol OST/week for 3 OST/week for 3
daily showed 7mm EMT. weeks, & oral weeks, & oral
estradiol daily estradiol daily
showed 6.7mm showed 6.7mm
EMT. EMT.
• In patient #3, even though she had a euploid embryo transferred and a
relatively thick EMT following OST, she did not get pregnant. There is
35% probability of not achieving a clinical pregnancy with a euploid
embryo, which is still not understood.